Hyderabad Telangana, India

Sathish Thumati

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Natco Pharma Limited. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sathish Thumati: Innovator in Pharmaceutical Processes

Introduction

Sathish Thumati is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. His work is characterized by a commitment to enhancing the efficiency and effectiveness of pharmaceutical compounds.

Latest Patents

Sathish Thumati holds a patent for the "Process for the preparation of ribociclib succinate and its novel crystalline forms thereof." This invention relates to an improved process for the preparation of 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate (1/1) compound of formula-1a and its novel crystalline forms. The compound is represented by a specific structural formula, which showcases the innovative nature of his work.

Career Highlights

Sathish Thumati is currently associated with Natco Pharma Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug formulation and process optimization. With a focus on innovation, he continues to contribute to the advancement of pharmaceutical technologies.

Collaborations

Sathish has collaborated with talented coworkers, including Arunkumar Thiriveedhi and Swapna Kondaveeti. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Sathish Thumati's contributions to the pharmaceutical industry exemplify the importance of innovation in drug development. His patent for the preparation of ribociclib succinate highlights his commitment to improving pharmaceutical processes. Through his work at Natco Pharma Limited and collaborations with skilled colleagues, he continues to make a significant impact in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…